Richard U. de Schutter, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 10,000 shares at $14.33 ($143K) on 2017-11-17, disclosed to the SEC on 2017-11-21.
Recurring purchase ($143k) by Director following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| BHC | BUY | 2018-09-17 | $3.0M | — | Filing → |
| VRX | BUY | 2018-07-03 | $218K | — | Filing → |
| VRX | BUY | 2018-05-17 | $327K | — | Filing → |